Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant.

BioRxiv : the Preprint Server for Biology
Ann-Kathrin ReuschlNevan J Krogan


Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths worldwide and massive societal and economic burden. Recently, a new variant of SARS-CoV-2, known as B.1.1.7, was first detected in the United Kingdom and is spreading in several other countries, heightening public health concern and raising questions as to the resulting effectiveness of vaccines and therapeutic interventions. We and others previously identified host-directed therapies with antiviral efficacy against SARS-CoV-2 infection. Less prone to the development of therapy resistance, host-directed drugs represent promising therapeutic options to combat emerging viral variants as host genes possess a lower propensity to mutate compared to viral genes. Here, in the first study of the full-length B.1.1.7 variant virus, we find two host-directed drugs, plitidepsin (aplidin; inhibits translation elongation factor eEF1A) and ralimetinib (inhibits p38 MAP kinase cascade), as well as remdesivir, to possess similar antiviral activity against both the early-lineage SARS-CoV-2 and the B.1.1.7 variant, evaluated in both human gastrointestinal and lung epithelial cell lines. We find that pliti...Continue Reading

Methods Mentioned

flow cytometry

Clinical Trials Mentioned


Related Concepts

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

MMWR. Morbidity and Mortality Weekly Report
Summer E GallowayVivien G Dugan
The Lancet. Respiratory Medicine
Robert J Wilkinson
MedRxiv : the Preprint Server for Health Sciences
V. V. EdaraMehul S Suthar
Annals of Internal Medicine
R B Stricker, B Goldberg
© 2021 Meta ULC. All rights reserved